E6/E7 oncogenes increase and tumor suppressors decrease the proportion of self-renewing neural progenitor cells

Oncogene

Volumn 25, Issue 35, 2006, Pages 4880-4889

  Piltti, K ^a   Kerosuo, L ^a   Hakanen, J ^b   Eriksson, M ^a   Angers Loustau, A ^a   Leppa S ^a   Salminen, M ^b   Sariola, H ^a,c   Wartiovaara, K ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Oncogene; Progenitor; Self renewal; Tumor suppressor

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; HUMAN PAPILLOMAVIRUS TYPE 6; MITOSIS INHIBITION; MOUSE; MULTIPOTENT STEM CELL; NERVE CELL CULTURE; NERVE REGENERATION; NEURAL STEM CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN METABOLISM; VIRUS ONCOGENE;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; GENES, TUMOR SUPPRESSOR; MICE; NEURONS; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; STEM CELLS;

HUMAN PAPILLOMAVIRUS;

EID: 33746887021     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209492     Document Type: Article

References (45)

1. Antinore MJ, Birrer MJ, Patel D, Nader L, McCance DJ. (1996). EMBO J 15: 1950-1960.
2. Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR. (1995). Curr Biol 5: 931-936.
3. Bach S, Knockaert M, Reinhardt J. (2005). J Biol Chem 280: 31208-31219.
4. Boyer SN, Wazer DE, Band V. (1996). Cancer Res 56: 4620-4624.
5. Bruggeman SW, Valk-Lingbeek ME, van der Stoop PP. (2005). Genes Dev 19: 1438-1443.
6. Callaghan DA, Dong L, Callaghan SM, Hou YX, Dagnino L, Slack RS. (1999). Dev Biol 207: 257-270.
7. Chakrabarti O, Veeraraghavalu K, Tergaonkar V. (2004). J Virol 78: 5934-5945.
8. Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, Chow LT. (1995). Genes Dev 9: 2335-2349.
9. Choi J, Donehower LA. (1999). Cell Mol Life Sci 55: 38-47.
10. Coursen JD, Bennett WP, Gollahon L, Shay JW, Harris CC. (1997). Exp Cell Res 235: 245-253.
11. Davies R, Hicks R, Crook T, Morris J, Vousden K. (1993). J Virol 67: 2521-2528.
12. Dazy S, Damiola F, Parisey N, Beug H, Gandrillon O. (2003). Oncogene 22: 9205-9216.
13. DeCaprio JA. (1999). Biologicals 27: 23-28.
14. Dyson N, Dembski M, Fattaey A, Ngwu C, Ewen M, Helin K. (1993). J Virol 67: 7641-7647.
15. Farah MH, Olson JM, Sucic HB, Hume RI, Tapscott SJ, Turner DL. (2000). Development 127: 693-702.
16. Favata MF, Horiuchi KY, Manos EJ. (1998). J Biol Chem 273: 18623-18632.
17. Fehrmann F, Laimins LA. (2003). Oncogene 22: 5201-5207.
18. Ferguson KL, Callaghan SM, O'Hare MJ, Park DS, Slack RS. (2000). J Biol Chem 275: 33593-33600.
19. Grewal SS, York RD, Stork PJ. (1999). Curr Opin Neurobiol 9: 544-553.
20. Halbert CL, Demers GW, Galloway DA. (1991). J Virol 65: 473-478.
21. Harris KF, Christensen JB, Radany EH, Imperiale MJ. (1998). Mol Cell Biol 18: 1746-1756.
22. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT. (1989). EMBO J 8: 3905-3910.
23. Herdegen T, Skene P, Bahr M. (1997). Trends Neurosci 20: 227-231.
24. Liu H, Dibling B, Spike B, Dirlam A, Macleod K. (2004). Curr Opin Genet Dev 14: 55-64.
25. Macleod KF, Hu Y, Jacks T. (1996). EMBO J 15: 6178-6188.
26. Meijer L, Borgne A, Mulner O. (1997). Eur J Biochem 243: 527-536.
27. Miller MW, Peter A, Wharton SB, Wyllie AH. (2003). Brain Res 965: 57-66.
28. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R. (2005). Genes Dev 19: 1432-1437.
29. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. (2003). Nature 425: 962-967.
30. Munger K, Baldwin A, Edwards KM. (2004). J Virol 78: 11451-11460.
31. Pardal R, Clarke MF, Morrison SJ. (2003). Nat Rev Cancer 3: 895-902.
32. Popsueva A, Poteryaev D, Arighi E. (2003). J Cell Biol 161: 119-129.
33. Ross SE, Greenberg ME, Stiles CD. (2003). Neuron 39: 13-25.
34. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. (1990). Cell 63: 1129-1136.
35. Singh SK, Clarke ID, Terasaki M. (2003). Cancer Res 63: 5821-5828.
36. Slack RS, El-Bizri H, Wong J, Belliveau DJ, Miller FD. (1998). J Cell Biol 140: 1497-1509.
37. Slack RS, Hamel PA, Bladon TS, Gill RM, McBurney MW. (1993). Oncogene 8: 1585-1591.
38. TeKippe M, Harrison DE, Chen J. (2003). Exp Hematol 31: 521-527.
39. Toma JG, Akhavan M, Fernandes KJ. (2001). Nat Cell Biol 3: 778-784.
40. Toma JG, El-Bizri H, Barnabe-Heider F, Aloyz R, Miller FD. (2000). J Neurosci 20: 7648-7656.
41. Tyner SD, Venkatachalam S, Choi J. (2002). Nature 415: 45-53.
42. van Houten VM, Snijders PJ, van den Brekel MW. (2001). Int J Cancer 93: 232-235.
43. Vanderluit JL, Ferguson KL, Nikoletopoulou V. (2004). J Cell Biol 166: 853-863.
44. Walboomers JM, Jacobs MV, Manos MM. (1999). J Pathol 189: 12-19.
45. Whyte P, Buchkovich KJ, Horowitz JM. (1988). Nature 334: 124-129.